Edesa Biotech Receives FDA Clearance for Phase 2 Vitiligo Study
The FDA cleared the investigational new drug application for Edesa Biotech’s Phase 2 vitiligo study.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.